These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 25422553)
1. Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression. Qiu J; Hu SY; Shi GQ; Wang SE Pharmacogn Mag; 2014 Oct; 10(40):503-8. PubMed ID: 25422553 [TBL] [Abstract][Full Text] [Related]
2. A Serum Pharmacochemistry and Network Pharmacology-based Approach to Study the Anti-depressant Effect of Chaihu-Shugan San. Deng MF; Yan YZ; Zhu SS; Zhou K; Tan SJ; Zeng P Comb Chem High Throughput Screen; 2024 Mar; ():. PubMed ID: 38551057 [TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like activity of Chaihu-Shugan-San aqueous extract in rats and its possible mechanism. Wang S; Hu S; Zhang C; Qiu J; Li Y Pharmacogn Mag; 2014 Jan; 10(Suppl 1):S50-6. PubMed ID: 24914308 [TBL] [Abstract][Full Text] [Related]
4. [Effects of Chaihu Shugan San on behavior and plasma levels of corticotropin releasing hormone and adrenocorticotropic hormone of rats with chronic mild unpredicted stress depression]. Li YH; Zhang CH; Wang SE; Qiu J; Hu SY; Xiao GL Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1073-7. PubMed ID: 19912741 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effects of Chaihu-Shugan-San via SAPK/JNK signal transduction in rat models of depression. Li YH; Zhang CH; Qiu J; Wang SE; Hu SY; Huang X; Xie Y; Wang Y; Cheng TL Pharmacogn Mag; 2014 Jul; 10(39):271-7. PubMed ID: 25210314 [TBL] [Abstract][Full Text] [Related]
6. Effect of Chaihu-Shugan-San on the mRNA expression of the 5-HT1A receptor and cellular proliferation in the hippocampus of epileptic rats with depression. Yang P; Li L; Liu XJ; Cai X; Sun MZ; He JF; Zeng G; Huang HY Exp Ther Med; 2016 Jan; 11(1):124-130. PubMed ID: 26889228 [TBL] [Abstract][Full Text] [Related]
7. Mechanism underlying effect of Chaihu Shugan San on major depressive disorder: a network pharmacology-based study. Mu J; Zhang S; Tang F; Liu S; Zhang Q; Du Q; Wang X; Wang Q; Cheng F J Tradit Chin Med; 2021 Apr; 41(2):338-348. PubMed ID: 33825416 [TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. Jiang WN; Li D; Jiang T; Guo J; Chen YF; Wang J; Zhou Y; Yang CY; Tang CP Chin J Integr Med; 2018 Feb; 24(2):125-132. PubMed ID: 27164963 [TBL] [Abstract][Full Text] [Related]
9. Exploring mechanisms of Chaihu-Shugan-San against liver fibrosis by integrated multi-omics and network pharmacology approach. Xie Z; Xie Z; Trujillo NP; Yang T; Yang C Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35791909 [TBL] [Abstract][Full Text] [Related]
10. Chaihu Shugan San promotes gastric motility in rats with functional dyspepsia by regulating Drp-1-mediated ICC mitophagy. Li L; Jia Q; Wang X; Wang Y; Wu C; Cong J; Ling J Pharm Biol; 2023 Dec; 61(1):249-258. PubMed ID: 36655341 [TBL] [Abstract][Full Text] [Related]
11. Effect of Chaihu Shugan San and its components on expression of ERK1/2 mRNA in the hippocampus of rats with chronic mild unpredicted stress depression. Wang S; Hu S; Zhang C; Qiu J; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):93-100. PubMed ID: 21368416 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous Determination of Five Components of Chaihu-Shugan-San in Beagle Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study after a Single Dose of Chaihu-Shugan-San. Zhu YL; Wang HJ; Xue H; Zhang Y; Cheng QS; Chen LY; Qiu XJ J Anal Methods Chem; 2020; 2020():8831938. PubMed ID: 32923002 [TBL] [Abstract][Full Text] [Related]
13. Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance. Jia KK; Pan SM; Ding H; Liu JH; Zheng YJ; Wang SJ; Pan Y; Kong LD Biomed Pharmacother; 2018 Jul; 103():1415-1428. PubMed ID: 29864926 [TBL] [Abstract][Full Text] [Related]
14. Towards characterizing the regional cerebral perfusion in evaluating the severity of major depression disorder with SPECT/CT. Li J; Yang Y; Zhu Y; Zhou L; Han Y; Yin T; Cheng Z; Zhang G; Shen Y; Chen J BMC Psychiatry; 2018 Mar; 18(1):70. PubMed ID: 29562903 [TBL] [Abstract][Full Text] [Related]
15. Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress. Zhu X; Li T; Hu E; Duan L; Zhang C; Wang Y; Tang T; Yang Z; Fan R Front Pharmacol; 2021; 12():791097. PubMed ID: 35111057 [No Abstract] [Full Text] [Related]
17. [Screening of specific microRNA in hippocampus of depression model rats and intervention effect of Chaihu Shugan San]. Cao MQ; Chen DH; Zhang CH; Wu ZZ Zhongguo Zhong Yao Za Zhi; 2013 May; 38(10):1585-9. PubMed ID: 23947143 [TBL] [Abstract][Full Text] [Related]
18. Changes in regional cerebral blood flow following antidepressant treatment in late-life depression. Ishizaki J; Yamamoto H; Takahashi T; Takeda M; Yano M; Mimura M Int J Geriatr Psychiatry; 2008 Aug; 23(8):805-11. PubMed ID: 18214999 [TBL] [Abstract][Full Text] [Related]
19. Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study. Skaf CR; Yamada A; Garrido GE; Buchpiguel CA; Akamine S; Castro CC; Busatto GF J Affect Disord; 2002 Apr; 68(2-3):295-305. PubMed ID: 12063157 [TBL] [Abstract][Full Text] [Related]
20. Changes in regional cerebral blood flow demonstrated by single photon emission computed tomography in depressive disorders: comparison of unipolar vs. bipolar subtypes. Tutus A; Simsek A; Sofuoglu S; Nardali M; Kugu N; Karaaslan F; Gönül AS Psychiatry Res; 1998 Sep; 83(3):169-77. PubMed ID: 9849726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]